top of page
Search

Lithium & Digoxin Toxicity for MRCP Part 1

TL;DR

Lithium and digoxin toxicity are repeatedly tested in MRCP Part 1, especially through clinical scenarios and ECG interpretation. Tox: Lithium Toxicity & Digoxin Toxicity focuses on recognising neurological features (lithium) versus cardiac arrhythmias (digoxin), alongside key triggers such as renal impairment and drug interactions. Understanding when to use haemodialysis or digoxin-specific Fab is essential for exam success.


Why this matters

Toxicology in MRCP Part 1 is less about rare poisons and more about commonly prescribed drugs with narrow therapeutic windows. Lithium (used in bipolar disorder) and digoxin (used in heart failure and atrial fibrillation) are classic examples.

Both drugs share three key exam principles:

  • Narrow therapeutic index

  • Renal excretion

  • Toxicity triggered by everyday clinical scenarios

If you master these, you can confidently tackle SBA questions. For broader exam preparation, explore the MRCP Part 1 overview.


Core sections

1. Lithium Toxicity: High-Yield Concepts

Pharmacology & Basics

  • Mood stabiliser for bipolar disorder

  • Therapeutic range: 0.4–1.0 mmol/L

  • Entirely renally excreted

Types of Toxicity (Exam Favourite)

  1. Acute overdose

  2. Chronic toxicity (most tested)

  3. Acute-on-chronic

Clinical Features

  • Neurological (key focus):

    • Coarse tremor

    • Ataxia

    • Dysarthria

    • Confusion → seizures → coma

  • GI: nausea, vomiting (early in acute toxicity)

  • Cardiac: mild ECG changes (less commonly tested)

Common Triggers

  • Dehydration

  • Acute kidney injury

  • Drug interactions:

    • ACE inhibitors

    • Thiazide diuretics

    • NSAIDs

Management

  • Stop lithium immediately

  • IV normal saline

  • Haemodialysis indications:

    • Severe neurological symptoms

    • Lithium >4 mmol/L (acute)

    • 2.5 mmol/L with symptoms (chronic)

2. Digoxin Toxicity: High-Yield Concepts

Mechanism

  • Inhibits Na⁺/K⁺-ATPase → ↑ intracellular calcium

  • Increases vagal tone

Therapeutic Range

  • 0.5–2.0 ng/mL

Clinical Features

  • Cardiac (most tested):

    • Bradycardia

    • AV block

    • Ventricular arrhythmias

  • Gastrointestinal:

    • Nausea, vomiting

  • Visual:

    • Yellow-green vision (xanthopsia)

ECG Findings

  • “Scooped” ST depression (reverse tick)

  • Atrial tachycardia with block (classic)

Risk Factors

  • Hypokalaemia

  • Renal impairment

  • Drug interactions (e.g. amiodarone, verapamil)

Management

  • Stop digoxin

  • Correct electrolytes

  • Digoxin-specific antibody fragments (Fab) for:

    • Life-threatening arrhythmias

    • Severe toxicity

3. Lithium vs Digoxin Toxicity (Comparison Table)

Feature

Lithium Toxicity

Digoxin Toxicity

Primary system

Neurological

Cardiac

Key symptoms

Tremor, ataxia, confusion

Arrhythmias, visual disturbance

ECG

Non-specific

Scooped ST depression

Triggers

Dehydration, ACEi, NSAIDs

Hypokalaemia, renal failure

Antidote

None

Digoxin Fab

Definitive treatment

Haemodialysis

Fab fragments

4. Five Most Tested Subtopics

  1. Drug interactions

    • Lithium + thiazide → toxicity

    • Digoxin + amiodarone → increased levels

  2. Electrolytes

    • Hypokalaemia worsens digoxin toxicity

    • Sodium depletion worsens lithium toxicity

  3. Renal function

    • Central to both toxicities

  4. ECG recognition

    • Digoxin patterns frequently appear in questions

  5. Antidote/dialysis indications

    • Common SBA focus

5. Eight High-Yield Exam Points

  1. Lithium toxicity = neurological signs dominate

  2. Chronic lithium toxicity is more dangerous

  3. Digoxin toxicity = arrhythmias are key

  4. Hypokalaemia increases digoxin toxicity

  5. Thiazides increase lithium levels

  6. Digoxin can cause any arrhythmia

  7. Lithium is dialysable

  8. Digoxin Fab is used in life-threatening cases


Practical examples / mini-cases

MCQ

A 75-year-old woman with atrial fibrillation presents with nausea, confusion, and yellow vision. ECG shows atrial tachycardia with block. Potassium is low.

What is the best management?

A. IV fluidsB. Potassium replacement onlyC. Digoxin-specific FabD. HaemodialysisE. Beta-blocker

Answer: C. Digoxin-specific Fab

Explanation: Classic digoxin toxicity with visual symptoms + arrhythmia + hypokalaemia. Life-threatening toxicity requires Fab fragments, not just supportive care.

Practise similar SBAs using Free MRCP MCQs or simulate exam conditions with a Start a mock test.


Medical student revising toxicology topics including lithium and digoxin toxicity for MRCP Part 1 exam

Common pitfalls (5 bullets)

  • Confusing lithium neurological toxicity with digoxin cardiac toxicity

  • Ignoring drug interactions (very frequently tested)

  • Missing electrolyte abnormalities (especially potassium)

  • Forgetting severity of chronic lithium toxicity

  • Not recognising when digoxin Fab is indicated


Practical study-tip checklist

  • Revise drug interaction tables weekly

  • Memorise ECG patterns visually

  • Focus on renal physiology links

  • Practise toxicity-based MCQs regularly

  • Use spaced repetition for antidotes

Supplement your prep with structured learning via MRCP Part 1 overview and targeted lectures.


FAQs

1. What is the hallmark of lithium toxicity in MRCP Part 1?

Neurological symptoms—especially tremor, ataxia, and confusion—are the most tested features.

2. Why does hypokalaemia worsen digoxin toxicity?

Low potassium increases digoxin binding to Na⁺/K⁺-ATPase, enhancing toxicity and arrhythmias.

3. When should haemodialysis be used in lithium toxicity?

In severe neurological symptoms or significantly elevated lithium levels (>4 mmol/L acute).

4. What is the antidote for digoxin toxicity?

Digoxin-specific antibody fragments (Fab), used in severe or life-threatening toxicity.

5. Which drugs commonly precipitate lithium toxicity?

Thiazides, ACE inhibitors, and NSAIDs are the most commonly tested triggers.


Ready to start?

Toxicology is a scoring area in MRCP Part 1 if approached systematically. Strengthen your preparation:


Sources

 
 
 

Comments

bottom of page